Fig. 2From: The prognostic factor for recurrence in advanced-stage high-grade serous ovarian cancer after complete clinical remission: a nested case-control studyA The serum CA-125 levels recorded (after primary treatment) during follow-up in each recurrent OC patients with a posttreatment CA-125 level > 10 U/ml. B The serum CA-125 levels recorded during follow-up in each recurrent OC patients with a posttreatment CA-125 level ≤ 10 U/mlBack to article page